Professor Keith Ferdinand, Tulane University School of Medicine, New Orleans, USA
Elevated Lp(a) is a strong, independent risk factor for the development of atherosclerotic cardiovascular disease (ASCVD) and calcified aortic valve stenosis, and elevated Lp(a) levels are present in perhaps 20% of people, or an estimated 1.4 billion people worldwide.1 It is therefore likely to be beneficial for everyone to be tested at least once in life, and that is now a recommendation in multiple international and national guidelines.1-3
